by David Burdette | Jan 1, 2026 | White Paper
Download and review a comprehensive white paper below that is a fresh look at what we (the authors) believe to be the major cause of most myopia. Read about the natural physiological tension that constantly is present in the human eye. This natural tension involves...
by David Burdette | Dec 1, 2025 | White Paper
NeuroRays™ Approach for Maximum Slowing or Stoppage of Myopia Progression* with Little, if any, Rebound Recommend Myopia Control Lenses Recommend NeuroRays Eclipse™ Ocular Light Therapy LLBL & LLRL with Macula Protection Under Development Recommend the Wear of...
by David Burdette | Aug 4, 2025 | White Paper
The three recommended steps: Apply Ocular Light Therapy While Protecting the Macula Utilize Myopia Control Lenses in Combination Continue with Myopia Control Lenses To Prevent Rebound The Proof! Low-Level Red-Light Therapy While Protecting the Macula Increases Myopia...
by David Burdette | Jul 1, 2025 | White Paper
There is clear evidence that light impacts our health and well-being. Besides the visual (image-forming) functions of the human ocular system, it is well known that it is also responsible for a number of non-visual functions, such as wake-sleep cycle, mood, alertness,...
by David Burdette | Jun 9, 2025 | White Paper
Figure 1. Schematic presentation of eye anatomy. Myopia, or nearsightedness, is the most common form of refractive abnormality and is characterized by excessive eye elongation, causing distant objects to appear blurry. Elongation of the eye is further enabled by the...
